Related references
Note: Only part of the references are listed.Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis
Zhennan Yun et al.
Aging-US (2021)
Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
Gang Bao et al.
CANCER MEDICINE (2020)
A Key mRNA-miRNA-lncRNA Competing Endogenous RNA Triple Sub-network Linked to Diagnosis and Prognosis of Hepatocellular Carcinoma
Junjie Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
MicroRNA-16-5p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells
Fang Wang et al.
ONCOLOGY REPORTS (2020)
lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression
Liang Yan et al.
MOLECULAR CARCINOGENESIS (2020)
LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells
Tianliang Bai et al.
IUBMB LIFE (2019)
LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis
Meng Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis
Xin Rui et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells
Fang Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer
Junyan Cai et al.
TUMOR BIOLOGY (2016)
Share Paper
